Last edition
News about "Type 1 diabetes"
Abbott has received CE Mark approval for Libre Duo, the world’s first dual glucose-ketone sensing technology, offering continuous monitoring of both glucose and ketone levels to help prevent diabetic ketoacidosis and support safer diabetes care.
Type 1 Diabetes | 30/05/2026 | By News Bureau
US FDA Approves Sanofi's Tzield to Delay Type 1 Diabetes Progression in Children
Sanofi’s Tzield gains US FDA approval to delay stage-III Type 1 Diabetes in children aged one year and above, the first disease-modifying therapy for stage-II T1D.
Type 1 Diabetes | 24/04/2026 | By News Bureau
GentiBio Doses First Patient in Phase I Trial of Novel Cell Therapy for Type 1 Diabetes
GentiBio initiates Phase I POLARIS trial of GNTI-122, an engineered Treg therapy aimed at preserving insulin production and reducing lifelong insulin dependence in newly diagnosed type 1 diabetes patients.
Type 1 Diabetes | 19/03/2026 | By News Bureau | 124
CHMP Recommends Sanofi's Tezeild for EU Approval in Stage 2 Type 1 Diabetes
The CHMP has backed EU approval for Sanofi’s Tezeild, supported by TN-10 study results showing the therapy can delay progression to stage 3 type 1 diabetes in patients with stage 2 disease. If authorised, Tezeild would become the first disease-modifying treatment for T1D in the EU.
Type 1 Diabetes | 15/11/2025 | By Dineshwori | 346
Modular Medical Completes MODD1 Clinical Study, Advances Toward Next-Gen Pivot Pump Launch
US-based insulin delivery technology company Modular Medical has announced the successful completion of a clinical study with its MODD1 pump.
Type 1 Diabetes | 12/09/2025 | By Dineshwori | 306
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy